P-163 Tyrosine kinase inhibitors (TKIs) plus transarterial chemoembolization (TACE) compared to TACE alone as downstaging therapy in transplant recipients with hepatocellular carcinoma: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022

A. Esmail; S. Kodali; E. Graviss; D. Nguyen; L. Moore; A. Saharia; A. Uosef; D. Victor; M. Abdelrahim

doi:10.1016/j.annonc.2022.04.253

P-163 Tyrosine kinase inhibitors (TKIs) plus transarterial chemoembolization (TACE) compared to TACE alone as downstaging therapy in transplant recipients with hepatocellular carcinoma: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022

A. Esmail, S. Kodali, E. Graviss, D. Nguyen, L. Moore, A. Saharia, A. Uosef, D. Victor, M. Abdelrahim

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	S308
Journal	Annals of Oncology
Volume	33
DOIs	https://doi.org/10.1016/j.annonc.2022.04.253
State	Published - 2022

Access to Document

10.1016/j.annonc.2022.04.253

https://www.sciencedirect.com/science/article/pii/S0923753422009437

Cite this

Esmail, A., Kodali, S., Graviss, E., Nguyen, D., Moore, L., Saharia, A., Uosef, A., Victor, D., & Abdelrahim, M. (2022). P-163 Tyrosine kinase inhibitors (TKIs) plus transarterial chemoembolization (TACE) compared to TACE alone as downstaging therapy in transplant recipients with hepatocellular carcinoma: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022. Annals of Oncology, 33, S308. https://doi.org/10.1016/j.annonc.2022.04.253

P-163 Tyrosine kinase inhibitors (TKIs) plus transarterial chemoembolization (TACE) compared to TACE alone as downstaging therapy in transplant recipients with hepatocellular carcinoma: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022. / Esmail, A.; Kodali, S.; Graviss, E. et al.
In: Annals of Oncology, Vol. 33, 2022, p. S308.

Research output: Contribution to journal › Article › peer-review

Esmail, A, Kodali, S , Graviss, E, Nguyen, D, Moore, L , Saharia, A, Uosef, A, Victor, D & Abdelrahim, M 2022, 'P-163 Tyrosine kinase inhibitors (TKIs) plus transarterial chemoembolization (TACE) compared to TACE alone as downstaging therapy in transplant recipients with hepatocellular carcinoma: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022', Annals of Oncology, vol. 33, pp. S308. https://doi.org/10.1016/j.annonc.2022.04.253

Esmail A, Kodali S , Graviss E, Nguyen D, Moore L , Saharia A et al. P-163 Tyrosine kinase inhibitors (TKIs) plus transarterial chemoembolization (TACE) compared to TACE alone as downstaging therapy in transplant recipients with hepatocellular carcinoma: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022. Annals of Oncology. 2022;33:S308. doi: 10.1016/j.annonc.2022.04.253

Esmail, A. ; Kodali, S. ; Graviss, E. et al. / P-163 Tyrosine kinase inhibitors (TKIs) plus transarterial chemoembolization (TACE) compared to TACE alone as downstaging therapy in transplant recipients with hepatocellular carcinoma : Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022. In: Annals of Oncology. 2022 ; Vol. 33. pp. S308.

@article{6b341f19e12340df97c9cbb96278b0a3,

title = "P-163 Tyrosine kinase inhibitors (TKIs) plus transarterial chemoembolization (TACE) compared to TACE alone as downstaging therapy in transplant recipients with hepatocellular carcinoma: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022",

author = "A. Esmail and S. Kodali and E. Graviss and D. Nguyen and L. Moore and A. Saharia and A. Uosef and D. Victor and M. Abdelrahim",

year = "2022",

doi = "10.1016/j.annonc.2022.04.253",

language = "English (US)",

volume = "33",

pages = "S308",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - P-163 Tyrosine kinase inhibitors (TKIs) plus transarterial chemoembolization (TACE) compared to TACE alone as downstaging therapy in transplant recipients with hepatocellular carcinoma

T2 - Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022

AU - Esmail, A.

AU - Kodali, S.

AU - Graviss, E.

AU - Nguyen, D.

AU - Moore, L.

AU - Saharia, A.

AU - Uosef, A.

AU - Victor, D.

AU - Abdelrahim, M.

PY - 2022

Y1 - 2022

U2 - 10.1016/j.annonc.2022.04.253

DO - 10.1016/j.annonc.2022.04.253

M3 - Article

SN - 0923-7534

VL - 33

SP - S308

JO - Annals of Oncology

JF - Annals of Oncology

ER -